How engineered nanoparticles affect allergic lung disease
Mechanisms of Nanoparticle Modulation of Allergic Lung Disease
This study is looking at how tiny particles called multi-walled carbon nanotubes might make asthma and other allergic lung problems worse by interacting with common allergens like dust mites, and it hopes to find new ways to help people breathe easier.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | North Carolina State University Raleigh NIH-funded |
| Lab location | 1 site (Raleigh, United States) |
| Project ID | NIH-10871815 on NIH RePORTER |
What this research studies
This research investigates the role of multi-walled carbon nanotubes (MWCNTs), a type of engineered nanoparticle, in worsening allergic lung diseases like asthma. The study focuses on how these nanoparticles interact with allergens, specifically house dust mite allergens, to form an 'allergen corona' that may increase the severity of airway disease. By understanding the mechanisms through which MWCNTs exacerbate allergic reactions, the research aims to identify new treatment strategies that could improve patient outcomes. The approach includes examining cellular responses and signaling pathways involved in allergic airway disease.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from allergic asthma or related airway diseases.
Not a fit: Patients with non-allergic asthma or those without any form of airway disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for managing allergic asthma and reducing its severity.
How similar studies have performed: While the specific approach of using MWCNTs in this context is novel, previous studies have shown that understanding allergen interactions can lead to significant advancements in asthma treatment.
Where this research is happening
Raleigh, United States
- North Carolina State University Raleigh — Raleigh, United States (Active)
Researchers
- Principal investigator: Bonner, James Christopher — North Carolina State University Raleigh
- Study coordinator: Bonner, James Christopher
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.